MICROBOT MEDICAL INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
MICROBOT MEDICAL INC. (MBOT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of 0.01 ILS/shares as of 2025-08-31, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2025-11-12
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $9.16.
- 2020-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $8.87.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $8.70.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $8.48.
USD/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2020-09-30 | $9.16 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $8.87 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $8.70 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $8.48 10-Q · filed 2020-11-16 | |
| 2019-09-30 | $9.90 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $9.39 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $8.95 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $8.45 10-K · filed 2020-04-14 | |
| 2018-09-30 | $7.80 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $0.46 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $0.13 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.95 10-K · filed 2019-04-01 | $0.13 10-K · filed 2018-04-02 |
| 2017-09-30 | $0.13 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $0.13 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $0.13 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $0.13 10-K · filed 2018-04-02 | $0.39 10-K · filed 2017-03-21 |
| 2015-12-31 | $0.28 10-K · filed 2017-03-21 | $3.13 10-K · filed 2016-03-15 |
| 2014-12-31 | $18.18 10-K · filed 2015-03-13 | |
| 2013-12-31 | $20.02 10-K · filed 2014-03-13 | |
| 2012-12-31 | $19.77 10-K · filed 2013-03-21 |
ILS/shares
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2025-08-31 | 0.01 ILS/shares 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |